PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer
| Image |  |
|---|---|
| Description | scientific article published in 2024 |
| Author/s |
author: Joshua T Mendell Yang Xie Kyung-Min Lee Emmanuel Bikorimana Lin Xu Ariella Hanker Fabiana Napolitano Ram S Mani Andrew Lemoff Carlos L Arteaga Joseph J Otto David Cescon |
| Publication date | March 13, 2024 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |